Predictors of a successful glucocorticoid tapering and withdrawal in an inception cohort of patients with lupus nephritis and associations with long-term outcomes and damage accrual.

IF 4.7 2区 医学 Q1 RHEUMATOLOGY
Ioannis E Michelakis, Alexandros Panagiotopoulos, Eleni Kapsia, John Boletis, Smaragdi Marinaki, Petros P Sfikakis, Maria G Tektonidou
{"title":"Predictors of a successful glucocorticoid tapering and withdrawal in an inception cohort of patients with lupus nephritis and associations with long-term outcomes and damage accrual.","authors":"Ioannis E Michelakis, Alexandros Panagiotopoulos, Eleni Kapsia, John Boletis, Smaragdi Marinaki, Petros P Sfikakis, Maria G Tektonidou","doi":"10.1136/rmdopen-2025-005877","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>The optimal duration of glucocorticoid (GC) treatment in lupus nephritis (LN) remains unclear. We examined predictors of GC tapering and discontinuation (D/C), flares during tapering and post-D/C and long-term outcomes.</p><p><strong>Methods: </strong>We analysed inception cohort data (1992-2021) from 136 patients with LN (median follow-up: 121 months) and applied regression models to assess predictors of successful GC D/C and long-term outcomes, including clinical/laboratory, histological and treatment characteristics.</p><p><strong>Results: </strong>Median time to 7.5 mg/day, 5 mg/day and GC D/C was 9, 12 and 29 months post-diagnosis, respectively. Composite complete renal response (CR) and Systemic Lupus Erythematosus Disease Activity Index (SLEDAI)-2K≤4, sustainedly attained until GC D/C (HR: 1.85, p=0.016), membranous LN (HR: 1.81, p=0.01) and persistent use of hydroxychloroquine (HR: 1.49, p=0.04) were associated with a shorter time to GC D/C. Patients diagnosed after 2010 achieved earlier GC D/C.Shorter time to CR (OR: 1.05, p=0.034) and Lupus Low Disease Activity State at tapering from 7.5 mg/day onwards (OR: 0.23, p=0.046) reduced flare risk during tapering. Definition Of Remission In Systemic Lupus Erythematosus (DORIS) complete remission at D/C (OR: 0.20, p=0.005) and persistent hydroxychloroquine use (OR: 0.28, p=0.031) protected against post-D/C renal flares. Neither higher initial GC dose (>40 mg/day) nor slower GC tapering prevented renal flares. Time to GC D/C (OR: 1.02/month, p=0.04) and flares (OR: 2.08, p=0.036) were associated with damage risk at the end of follow-up.</p><p><strong>Conclusion: </strong>Sustained CR/SLEDAI-2K≤4, membranous LN and persistent hydroxychloroquine use emerged as main predictors of shorter time to D/C, while DORIS complete remission at D/C and persistent hydroxychloroquine use predicted post-DC flares. Time to GC D/C and flares independently contributed to 10-year damage accrual.</p>","PeriodicalId":21396,"journal":{"name":"RMD Open","volume":"11 4","pages":""},"PeriodicalIF":4.7000,"publicationDate":"2025-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12542714/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"RMD Open","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/rmdopen-2025-005877","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: The optimal duration of glucocorticoid (GC) treatment in lupus nephritis (LN) remains unclear. We examined predictors of GC tapering and discontinuation (D/C), flares during tapering and post-D/C and long-term outcomes.

Methods: We analysed inception cohort data (1992-2021) from 136 patients with LN (median follow-up: 121 months) and applied regression models to assess predictors of successful GC D/C and long-term outcomes, including clinical/laboratory, histological and treatment characteristics.

Results: Median time to 7.5 mg/day, 5 mg/day and GC D/C was 9, 12 and 29 months post-diagnosis, respectively. Composite complete renal response (CR) and Systemic Lupus Erythematosus Disease Activity Index (SLEDAI)-2K≤4, sustainedly attained until GC D/C (HR: 1.85, p=0.016), membranous LN (HR: 1.81, p=0.01) and persistent use of hydroxychloroquine (HR: 1.49, p=0.04) were associated with a shorter time to GC D/C. Patients diagnosed after 2010 achieved earlier GC D/C.Shorter time to CR (OR: 1.05, p=0.034) and Lupus Low Disease Activity State at tapering from 7.5 mg/day onwards (OR: 0.23, p=0.046) reduced flare risk during tapering. Definition Of Remission In Systemic Lupus Erythematosus (DORIS) complete remission at D/C (OR: 0.20, p=0.005) and persistent hydroxychloroquine use (OR: 0.28, p=0.031) protected against post-D/C renal flares. Neither higher initial GC dose (>40 mg/day) nor slower GC tapering prevented renal flares. Time to GC D/C (OR: 1.02/month, p=0.04) and flares (OR: 2.08, p=0.036) were associated with damage risk at the end of follow-up.

Conclusion: Sustained CR/SLEDAI-2K≤4, membranous LN and persistent hydroxychloroquine use emerged as main predictors of shorter time to D/C, while DORIS complete remission at D/C and persistent hydroxychloroquine use predicted post-DC flares. Time to GC D/C and flares independently contributed to 10-year damage accrual.

在狼疮肾炎患者的初始队列中成功的糖皮质激素减量和停药的预测因素以及与长期预后和损害累积的关联。
目的:糖皮质激素(GC)治疗狼疮性肾炎(LN)的最佳持续时间尚不清楚。我们检查了GC逐渐减少和终止(D/C)的预测因素,逐渐减少期间和D/C后的耀斑以及长期结果。方法:我们分析了136例LN患者的初始队列数据(1992-2021)(中位随访时间:121个月),并应用回归模型评估GC / D/C成功的预测因素和长期结果,包括临床/实验室、组织学和治疗特征。结果:7.5 mg/天、5 mg/天和GC D/C的中位时间分别为诊断后9、12和29个月。复合完全肾反应(CR)和系统性红斑狼疮疾病活动指数(SLEDAI)-2K≤4,持续达到GC D/C (HR: 1.85, p=0.016),膜性LN (HR: 1.81, p=0.01)和持续使用羟氯喹(HR: 1.49, p=0.04)与较短的GC D/C时间相关。2010年以后诊断的患者GC / D/C较早。从7.5 mg/天开始逐渐减少,较短的时间达到CR (OR: 1.05, p=0.034)和狼疮低疾病活动状态(OR: 0.23, p=0.046)降低了逐渐减少期间的发作风险。系统性红斑狼疮(DORIS)在D/C时完全缓解(OR: 0.20, p=0.005)和持续使用羟氯喹(OR: 0.28, p=0.031)可防止D/C后肾脏耀斑。较高的初始GC剂量(40mg /天)和较慢的GC逐渐减少均不能预防肾耀斑。随访结束时,GC时间D/C (OR: 1.02/月,p=0.04)和耀斑(OR: 2.08, p=0.036)与损伤风险相关。结论:持续CR/SLEDAI-2K≤4、膜性LN和持续使用羟氯喹是缩短D/C时间的主要预测因素,而D/C时DORIS完全缓解和持续使用羟氯喹可预测dc后发作。到GC、D/C和耀斑的时间分别对10年累积损害有贡献。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
RMD Open
RMD Open RHEUMATOLOGY-
CiteScore
7.30
自引率
6.50%
发文量
205
审稿时长
14 weeks
期刊介绍: RMD Open publishes high quality peer-reviewed original research covering the full spectrum of musculoskeletal disorders, rheumatism and connective tissue diseases, including osteoporosis, spine and rehabilitation. Clinical and epidemiological research, basic and translational medicine, interesting clinical cases, and smaller studies that add to the literature are all considered.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信